Previous close | 48.50 |
Open | 47.85 |
Bid | 46.45 |
Ask | 51.90 |
Strike | 1,100.00 |
Expiry date | 2025-08-15 |
Day's range | 47.85 - 48.05 |
Contract range | N/A |
Volume | |
Open interest | 15 |
Eli Lilly (LLY) concluded the recent trading session at $887.16, signifying a +0.18% move from its prior day's close.
FDA approves Sanofi's Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research site in Indiana.
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand. What does that mean for the marketplace?